Erratum to Placebo controls: Historical, methodological and general aspects (Phil. Trans. R. Soc. B (2011), 366, (1870-1878), 10.1098/rstb.2010.0401);Placebo controls: Historical, methodological and general aspects

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1572, 2011, Pages 1870-1878

  Walach, Harald ^a  

^a EUROPEAN UNIVERSITY VIADRINA   (Germany)

Author keywords

Double blind; Efficacy; Paradox; Placebo effect

Indexed keywords

DRUG; HIERARCHICAL SYSTEM; HISTORICAL PERSPECTIVE; PSYCHOLOGY;

EID: 79956348310     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0127     Document Type: Erratum

References (57)

1. Frank, J. D. 1961 Persuasion and healing: a comparative study of psychotherapy. Baltimore, MD: Johns Hopkins University Press.
2. Plato. 1964 Plato with an english translation by W.R.M. Lamb. London, UK: Heinemann. The Loeb Classical Library. (Plato I: Charmides, Alcibiades I & II, etc.).
3. nd edn. New York, NY: Wiley.
4. de Craen, A. J. M., Kaptchuk, T. J., Tijssen, J. G. P. & Kleijnen, J. 1999 Placebos and placebo effects in medicine: historical overview. J.R. Soc. Med. 92, 511-515.
5. Kaptchuk, T. J. 1998 Powerful placebo: the dark side of the randomised controlled trial. Lancet 351, 1722-1725. (doi:10.1136/bmj.39524.439618.25)
6. Florey, E. 1995 Ars Magnetica. Franz Anton Mesmer 1734-1815: Magier vom Bodensee. Konstanz: Universitätsverlag Konstanz.
7. Kaptchuk, T. J. 1998 Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull. Hist. Med. 72, 389-433. (doi:10.1353/bhm.1998.0159)
8. Miller, J. 1997 Going unconscious. In Hidden histories of science (ed. R. B. Silver), pp. 1-35. London, UK: Granta Books.
9. Crabtree, A. 1993 From Mesmer to Freud: magnetic sleep and the roots of psychological healing. New Haven, CT: Yale University Press.
10. Bailly, J. S. & Academic des Sciences (France).1784 Rapport des Commissaires chargés par le Roi de l'examen du Magnétisme Animal. Paris, Italy: Imprimerie Royale.
11. Ellenberger, H. F. 1970 The discovery of the unconscious. The history and evolution of dynamic psychiatry. New York, NY: Basic Books.
12. Shamdasani, S. 2003 Jung and the making of modern psychology: the dream of a science. Cambridge, UK: Cambridge University Press.
13. Stolberg, M. 1996 Die Homöopathie auf dem Prüfstein. Der erste Doppelblindversuch der Medizingeschichte im Jahr 1835. Munchn. Med. Wochen 138, 364-366.
14. Kaptchuk, T. J. 1997 Early use of blind assessment in a homoeopathic scientific experiment. Br. Homoeopath. J. 86, 49-50. (doi:10.1016/S0007-0785(97)80036-1)
15. Peirce, C. S. & Jastrow, J. 1884 On small differences of sensation. Messages Natl Acad. Sci. 3, 73-83.
16. Martini, P. 1932 Methodenlehre der therapeutischen Untersuchung. Berlin, Germany: Springer.
17. Therapy, C. 1954 How to evaluate a new drug. Am. J. Med. 17, 722-727. (doi:10.1016/0002-9343(54)90031-5)
18. Therapy, C. 1946 The use of placebos in therapy. New York J. Med. 46, 1718-1727.
19. Kleijnen, J., de Craen, A. J. M., Van Everdingen, J. & Krol, L. 1994 Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 344, 1347-1349. (doi:10.1016/S0140-6736(94)90699-8)
20. Brody, H. & Moerman, D. E. 1996. Symbolic and meaningful dimensions of the placebo effect. In Placebo and Nocebo Effects: Developing a Research Agenda Conf., 2-4 December. Bethesda, MD: NIH.
21. Moerman, D. E. & Jonas, W. B. 2002 Deconstructing the placebo effect and finding the meaning response. Ann. Intern. Med. 136, 471-476.
22. Moerman, D. E. et al. 1996 Placebo effects and research in alternative and conventional medicine. Chin J. Integr. Trad.West Med. 2, 141-148. (doi:10.1007/BF02969672)
23. Hulswit, M. 2000 A Semeiotic account of causation. The 'Cement of the Universe' from a Peircean Perspective. PhD Thesis, Katholieke Universiteit Nijmegen, Nijmegen, The Netherlands.
24. Peirce, C. S. 1992 The essential writings. Selected philosophical writings. Vol 1: 1867-1893; Vol 2: 1893-1913. Bloomington, IN: Indiana University Press.
25. Sebeok, T.A. 1986. The doctrine of signs. J. Soc. Biol. Struct. 9, 345-352. (doi:10.1016/S0140-1750(86) 90203-4)
26. Peirce, C. S. 1931 Collected papers, vol. 1-6; vol. 7-8 (eds C. Hartshorne, P. Weiss & A. Burks). Cambridge, MA: Harvard University Press.
27. Sebeok, T.A. 1972 Perspect zoosemiotics. The Hague: Mouton.
28. Yates, F. E. 1991 Pharmacosemiotics: where is the message in the drug? In Semiotic perspectives on clinical theory and practice medicine, neuropsychiatry and psychoanalysis (eds B. E. Litowitz & P. S. Epstein), pp. 65-79. Berlin, Germany: Mouton de Gruyter.
29. Uexküll, J. V. & Kriszat, G. 1970 Streifzüge durch die Umwelt von Tieren und Menschen. Bedeutungslehre. Stuttgart, Germany: Fischer.
30. Hoffmeyer, J. 1996 Für eine semiotisch reformulierte Naturwissenschaft. Z. Semiotik. 1, 31-34.
31. von Uexküll, T. 1982 Semiotics and medicine. Semiotica 38, 205-215. (doi:10.1515/semi.1982.38.3-4.205)
32. von Uexküll, T. 1986 Commentaries on 'The doctrine of signs' by Thomas Sebeok. J. Soc. Biol. Struct. 9, 353-354. (doi:10.1016/S0140-1750(86)90216-2)
33. von Uexküll, T. 1989 Naturwissenschaft als Zeichenlehre. Merkur-Deut Z Eur D 43, 225-234.
34. von Uexküll, T. 1995 Biosemiotic research and not further molecular analysis is necessary to describe pathways between cells, personalities, and social systems. Adv. J. Mind Body Health 11, 24-27.
35. von Uexküll, T. & Wesiack, W. 1988 Theorie der Humanmedizin. Grundlagen ärztlichen Denkens und Handelns. München, Germany: Urban & Schwarzenberg.
36. Hahn, R. A. 1997 The nocebo phenomenon: scope and foundations. In The placebo effect: an interdisciplinary exploration (ed. A. Harrington), pp. 56-76. Cambridge, MA: Harvard University Press.
37. Borkovec, T. D. 1985 Placebo: defining the unknown. In Placebo (eds L. White & B. Tursky), pp. 59-67. New York, NY: Guilford Press.
38. Grünbaum, A. 1981 The placebo concept. Behav. Res. Ther. 19, 157-167. (doi:10.1016/0005-7967(81)90040-1)
39. Grünbaum, A. 1989 The placebo concept in medicine and psychiatry. In Non-Specific aspects of treatment (eds M. Shepherd & N. Sartorius), pp. 7-38. Toronto: Huber.
40. Kienle, G. S. & Kiene, H. 1997 The powerful placebo effect: fact or fiction? J. Clin. Epidemiol. 50, 1311-1318. (doi:10.1016/S0895-4356(97)00203-5)
41. Walach, H. 2001 Das Wirksamkeitsparadox in der Komplementa ̈rmedizin. Forsch. Komp. Klas. Nat. 8, 193-195. (doi:10.1159/000057221)
42. Walach, H. 2001 The efficacy paradox in randomizedcontrolled trials of CAM and elsewhere: beware of the placebo trap. J. Altern. Complem. Med. 7, 213-218. (doi:10.1089/107555301300328070)
43. Haake, M., Muller, H. H., Schade-Brittinger, C., Basler, H. D., Schafer, H., Maier, C., Endres, H. G., Trampisch, H. J. & Molsberger, A. 2007 German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch. Intern. Med. 167, 1892-1898. (doi:10.1001/archinte.167.17.1892)
44. Scharf, H.-P., Mansmann, U., Streitberger, K., Witte, S., Krämer, J., Maier, C., Trampisch, H. J. & Victor, N. 2006 Acupuncture and knee osteoarthritis. Ann. Intern. Med. 145, 12-20.
45. Diener, H. C. et al. 2006 Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 5, 310-316. (doi:10.1016/S1474-4422(06)70382-9)
46. Cherkin, D. C. et al. 2009 A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch. Intern. Med. 169, 858-866. (doi:10.1001/archinternmed.2009.65)
47. Skovlund, E. 1991 Should we tell trials patients that they might receive placebo? Lancet 337, 1041. (doi:10.1016/0140-6736(91)92701-3)
48. Skovlund, E., Fyllingen, G., Landre, H. & Nesheim, B.-I. 1991 Comparison of postpartum pain treatments using a sequential trial design I: paracetamol versus placebo. Eur. J. Clin. Pharmacol. 40, 343-347. (doi:10.1007/BF00265841)
49. Skovlund, E., Fyllingen, G., Landre, H. & Nesheim, B.-I. 1991 Comparison of postpartum pain treatments using a sequential trial design II: naproxen versus paracetamol. Eur. J. Clin. Pharmacol. 40, 539-542. (doi:10.1007/BF00279965)
50. Bergmann, J.-F., Chassany, O., Gandiol, J., Deblos, P., Kanis, J. A., Segrestaa, J. M., Caulin, C. & Dahan, R. 1994 A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer patients. Clin. Trial Meta-Anal. 29, 41-47.
51. Diener, H. C. & Klein, K. B. Group MOCaSCS. 1996 The first comparison of the efficacy and safety of 311C90 and sumatriptan in the treatment of migraine. In 3rd European Headache Conf., 5-8 June. Italy: S Margherita di Pula.
52. Diener, H.-C., Dowson, A. J., Ferrari, M., Nappi, G. & Tfelt-Hansen, P. 1999 Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19, 699-700. (doi:10.1046/j.1468-2982.1999.019008699.x)
53. Whitmarsh, T. E., Coleston-Shields, D. M. & Steiner, T. J. 1997 Double-blind randomized placeo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 17, 600-604. (doi:10.1046/j.1468-2982.1997.1705600.x)
54. Walach, H., Gaus, W., Haeusler, W., Lowes, T., Mussbach, D., Schamell, U., Springer, W., Stritzl, W. & Haag, G. 1997 Classical homoeopathic treatment of chronic headaches. A double-blind, randomized, placebo-controlled study. Cephalalgia 17, 119-126.(doi:10.1046/j.1468-2982.2000.00129.x)
55. Straumsheim, P., Borchgrevink, C., Mowinkel, P., Kierulf, H. & Hafslund, O. 2000 Homoepathic treatment of migraine: a double blind, placebo controlled trial of 68 patients. Br. Homoeopath. J. 89, 4-7. (doi:10.1054/homp.1999.0332)
56. Witt, C. M., Lüdtke, R. & Willich, S. N. 2009 Homeopathic treatment of chronic headache (ICD-9: 784.0)-a prospective observational study with 2 year follow-up. Forsch Komplementmed 16, 227-235. (doi:10.1159/000226770)
57. Walach, H., Falkenberg, T., Fonnebo, V., Lewith, G. & Jonas, W. 2006 Circular instead of hierarchical-methodological principles for the evaluation of complex interventions. BMC Med. Res. Method 6, 29. (doi:10.1186/1471-2288-6-29)